news
Scmp World
2026-09-10
Hong Kong regulator suspends Cloudbreak Pharma over alleged IPO rigging
Hong Kong's SFC has suspended trading for Cloudbreak Pharma, launching an investigation into whether the company artificially inflated demand during its 2023 IPO.